# Varex Imaging Corporation (VREX) Stock Analysis: Exploring a 41.68% Potential Upside in the Healthcare Sector

- Link: https://www.directorstalkinterviews.com/varex-imaging-corporation-vrex-stock-analysis-exploring-a-41-68-potential-upside-in-the-healthcare-sector/4121232090
- Published: 2025-12-25T11:09:44+00:00
- Author: Madison Wilson

Varex Imaging Corporation (NASDAQ: VREX), a key player in the healthcare sector,
primarily focuses on the design and manufacture of X-ray imaging components. Operating
through two distinct segments—Medical and Industrial—Varex has carved out a niche
in both medical diagnostics and industrial inspection. With a market capitalization
of $506.11 million and its headquarters in Salt Lake City, Utah, Varex’s reach extends
globally, serving markets across North America, Europe, and Asia.

The company’s stock is currently priced at $12.14, with a modest change of 0.08 (
0.01%) in recent trading. The 52-week range stands between $6.88 and $15.20, illustrating
some volatility yet potential for strategic gains. Notably, analysts have set a 
target price range of $12.00 to $22.00, with an average target price of $17.20, 
suggesting a significant potential upside of 41.68% from current levels.

Despite the absence of a trailing P/E ratio, Varex’s forward P/E of 12.61 indicates
an expectation of earnings growth in the near future. However, the company faces
challenges such as a negative EPS of -1.70 and a return on equity of -13.58%, which
could raise concerns about profitability and efficiency. Yet, the positive revenue
growth of 11.30% and free cash flow of $39.53 million offer a counterbalance and
a promising outlook.

Varex’s performance metrics reveal a company in transition. While net income figures
are not available, the company’s robust free cash flow suggests significant operational
cash generation capabilities, essential for reinvestment and debt management. Moreover,
with no current dividend yield, Varex appears to be reinvesting its earnings back
into the business, a strategy often favored in growth phases.

On the technical front, Varex’s 50-day moving average stands at $11.72, while the
200-day moving average is $10.08, indicating a positive short-term trend. The Relative
Strength Index (RSI) of 23.91 suggests that the stock is currently oversold, potentially
presenting a buying opportunity for value-seeking investors. The Moving Average 
Convergence Divergence (MACD) of 0.17 and signal line of 0.11 further support a 
bullish sentiment, albeit with caution.

Analyst ratings are generally favorable, with four buy recommendations and one hold,
and no sell ratings, reinforcing the sentiment of potential growth. As Varex continues
to innovate with its medical and industrial imaging technologies, its strategic 
focus on global markets and expanding applications in security and inspection hold
promise for long-term investors.

For individual investors considering Varex Imaging, the potential upside, bolstered
by strategic market positioning and product innovation, presents an intriguing proposition.
However, investors should weigh the company’s current profitability challenges against
its growth potential and market opportunities. As always, thorough due diligence
and consideration of market conditions are recommended when evaluating VREX as a
potential addition to your investment portfolio.

Share on:
